Home Top Stories Girona FC extends its agreement with HYLO®

Girona FC extends its agreement with HYLO®

0
Girona FC extends its agreement with HYLO®

Girona FC extends agreement with HYLO®

Girona FC has extended the agreement with Brill Pharma, the pharmaceutical company responsible for the distribution in Spain of the HYLO® range, belonging to the prestigious German group Ursapharm, for another three seasons. The HYLO® brand will remain on the sleeve of the playing shirt in a historic campaign for the Club, which will compete in the Champions League. This milestone not only underlines the level of sporting success of Girona FC, but also provides an unparalleled platform for the promotion of HYLO® and Brill Pharma at international level.

This strategic partnership will not only bring significant benefits to the club, but will also increase the visibility of the HYLO® and Brill Pharma brand in the dynamic football world and among Girona FC’s passionate fans.

The extension of this agreement reaffirms Girona FC’s commitment to excellence and willingness to collaborate with leading brands. Known for its effectiveness in eye care, HYLO® has established itself as the reference in the field of dry eye in Spain, and this strategic alliance will further strengthen its presence in the sports sector.

The collaboration between Girona FC and Brill Pharma is a clear demonstration of the mutual commitment to excellence and innovation. We are confident that this partnership will continue to be fruitful and beneficial for both parties, contributing to the success of the Club and the growth of the HYLO® brand in the market.

About Brill Pharma

Brill Pharma is a leading Spanish pharmaceutical company specialized in ophthalmic products. As the exclusive distributor of the HYLO® range in Spain, Brill Pharma is committed to providing innovative and effective eye care solutions.

About HYLO®

HYLO® is the leading brand in the treatment of dry eyes, offering high-quality products that soothe and protect dry eyes. Owned by the German Ursapharm Group, HYLO® has established itself as a market leader thanks to its efficacy and safety.

NO COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Exit mobile version